These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11467412)

  • 1. Streptozotocin and alloxan-based selection improves toxin resistance of insulin-producing RINm cells.
    Bloch KO; Zemel R; Bloch OV; Grief H; Vardi P
    Int J Exp Diabetes Res; 2000; 1(3):211-9. PubMed ID: 11467412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic differentiation of tumor-derived insulin-producing cells selected for resistance to diabetogenic drugs.
    Bloch K; Vardi P
    Int J Exp Diabetes Res; 2000; 1(3):233-7. PubMed ID: 11467414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of insulin-producing rat insulinoma (RINm) cells with improved resistance to oxidative stress.
    Bloch KO; Vorobeychik M; Yavrians K; Vardi P
    Biochem Pharmacol; 2003 Jun; 65(11):1797-805. PubMed ID: 12781331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved activity of streptozotocin-selected insulinoma cells following microencapsulation and transplantation into diabetic mice.
    Bloch K; Vorobeychik M; Yavrians K; Azarov D; Bloch O; Vardi P
    Cell Biol Int; 2006 Feb; 30(2):138-43. PubMed ID: 16448824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cytotoxic agents on functional integrity and antioxidant enzymes in clonal beta-cells.
    Picton SF; McCluskey JT; Flatt PR; McClenaghan NH
    Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S70-7; discussion 3S108-12. PubMed ID: 12688636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF protects pancreatic β cells (RIN5F) against cytotoxic action of alloxan, streptozotocin, doxorubicin and benzo(a)pyrene in vitro.
    Bathina S; Srinivas N; Das UN
    Metabolism; 2016 May; 65(5):667-684. PubMed ID: 27085775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity.
    Liu HK; McCluskey JT; McClenghan NH; Flatt PR
    Endocrine; 2007 Aug; 32(1):20-9. PubMed ID: 17992598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-cell toxins on genetically engineered insulin-secreting cells.
    Tuch BE; Beynon S; Tabiin MT; Sassoon R; Goodman RJ; Simpson AM
    J Autoimmun; 1997 Jun; 10(3):239-44. PubMed ID: 9218749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan.
    Elsner M; Tiedge M; Guldbakke B; Munday R; Lenzen S
    Diabetologia; 2002 Nov; 45(11):1542-9. PubMed ID: 12436338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism underlying resistance of human pancreatic beta cells against toxicity of streptozotocin and alloxan.
    Elsner M; Tiedge M; Lenzen S
    Diabetologia; 2003 Dec; 46(12):1713-4. PubMed ID: 14614558
    [No Abstract]   [Full Text] [Related]  

  • 11. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury.
    Eizirik DL; Pipeleers DG; Ling Z; Welsh N; Hellerström C; Andersson A
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9253-6. PubMed ID: 7937750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iterative exposure of clonal BRIN-BD11 cells to ninhydrin enables selection of robust toxin-resistant cells but with decreased gene expression of insulin secretory function.
    Liu HK; McCluskey JT; McClenghan NH; Flatt PR
    Pancreas; 2008 Apr; 36(3):294-301. PubMed ID: 18362844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretion, insulin content and glucose phosphorylation in RINm5F insulinoma cells after transfection with human GLUT2 glucose-transporter cDNA.
    Tiedge M; Höhne M; Lenzen S
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):113-8. PubMed ID: 8250830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin.
    Hosokawa M; Dolci W; Thorens B
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1114-7. PubMed ID: 11741307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytotoxic drugs and inhibitors of insulin secretion on a serially transplantable rat insulinoma and cultured rat insulinoma cells.
    Flatt PR; Swanston-Flatt SK; Tan KS; Marks V
    Gen Pharmacol; 1987; 18(3):293-7. PubMed ID: 3032737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-cell maturation leads to in vitro sensitivity to cytotoxins.
    Nielsen K; Karlsen AE; Deckert M; Madsen OD; Serup P; Mandrup-Poulsen T; Nerup J
    Diabetes; 1999 Dec; 48(12):2324-32. PubMed ID: 10580420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotective effects of polyenoylphosphatidylcholine (PPC) on beta-cells during diabetic induction by streptozotocin.
    Lee SH; Han YM; Min BH; Park IS
    J Histochem Cytochem; 2003 Aug; 51(8):1005-15. PubMed ID: 12871982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human GLUT-2 overexpression does not affect glucose-stimulated insulin secretion in MIN6 cells.
    Ishihara H; Asano T; Tsukuda K; Katagiri H; Inukai K; Anai M; Yazaki Y; Miyazaki J; Kikuchi M; Oka Y
    Am J Physiol; 1995 Nov; 269(5 Pt 1):E897-902. PubMed ID: 7491941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.